, Volume 191, Issue 1, pp 43–52 | Cite as

Is There an Added Value of Cardiopulmonary Exercise Testing in Sarcoidosis Patients?

  • Rik G. J. Marcellis
  • Antoine F. Lenssen
  • Geeuwke J. de Vries
  • Robert P. Baughman
  • Chris P. van der Grinten
  • Johny A. Verschakelen
  • Jolanda De Vries
  • Marjolein Drent



Cardiopulmonary exercise testing (CPET) with blood gas analysis may be helpful when there is a discrepancy between clinical findings and physiologic tests at rest. The aim of this study was to examine the added value of CPET compared to the measurement of the diffusing capacity of the lung for carbon monoxide (DLCO) in detecting impaired pulmonary gas exchange in sarcoidosis patients.


The clinical records of 160 (age = 41.3 ± 10.0 years; number of females = 63) sarcoidosis patients referred to the former MUMC ild care center were retrospectively reviewed. Patients performed a symptom-limited incremental exercise test with blood gas analysis on a bicycle ergometer. DLCO was measured by the single-breath method.


DLCO (mean = 83.2 ± 18.0 %) below 80 % of predicted was demonstrated by 38 % of the sarcoidosis patients in our sample. Of the patients with normal DLCO (n = 99, 61.9 %), the P(A-a)O2 at maximal exercise [P(A-a)O2max] was moderately increased (>2.5 kPa) in 69.7 % and excessively increased (>4.7 kPa) in 18.2 %. Pulmonary gas exchange impairment (PGEI) was more obvious in patients with lower DLCO values. A DLCO value below 60 % of predicted indicated substantial gas exchange impairment. PaO2 at rest, DLCO, and FVC as a percentage of predicted and radiographic staging predicted 40 % of the PGEI at maximal exercise.


A substantial number of the symptomatic sarcoidosis patients with normal DLCO appeared to have PGEI at maximal exercise, suggesting that normal DLCO at rest is an inappropriate predictor of abnormal pulmonary gas exchange during exercise. CPET appeared to offer added value in detecting impaired gas exchange during exercise in sarcoidosis patients with unexplained disabling symptoms.


Sarcoidosis Cardiopulmonary exercise testing DLCO Pulmonary gas exchange impairment Muscle strength Lung function 


  1. 1.
    No authors listed (1999) Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160(2):736–755Google Scholar
  2. 2.
    Baughman RP, Culver DA, Judson MA (2011) A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med 183(5):573–581PubMedCrossRefGoogle Scholar
  3. 3.
    Baughman RP, Nunes H (2012) Therapy for sarcoidosis: evidence-based recommendations. Expert Rev Clin Immunol 8(1):95–103PubMedCrossRefGoogle Scholar
  4. 4.
    Morgenthau AS, Iannuzzi MC (2011) Recent advances in sarcoidosis. Chest 139(1):174–182PubMedCrossRefGoogle Scholar
  5. 5.
    Iannuzzi MC, Rybicki BA, Teirstein AS (2007) Sarcoidosis. N Engl J Med 357(21):2153–2165PubMedCrossRefGoogle Scholar
  6. 6.
    Wirnsberger RM, de Vries J, Wouters EF, Drent M (1998) Clinical presentation of sarcoidosis in The Netherlands an epidemiological study. Neth J Med 53(2):53–60PubMedCrossRefGoogle Scholar
  7. 7.
    Michielsen HJ, Drent M, Peros-Golubicic T, De Vries J (2006) Fatigue is associated with quality of life in sarcoidosis patients. Chest 130(4):989–994PubMedCrossRefGoogle Scholar
  8. 8.
    Elfferich MD, Nelemans PJ, Ponds RW, De Vries J, Wijnen PA, Drent M (2010) Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-alpha treatment. Respiration 80:212–219PubMedCrossRefGoogle Scholar
  9. 9.
    Korenromp IH, Heijnen CJ, Vogels OJ, van den Bosch JM, Grutters JC (2011) Characterization of chronic fatigue in patients with sarcoidosis in clinical remission. Chest 140(2):441–447PubMedCrossRefGoogle Scholar
  10. 10.
    Baydur A, Alavy B, Nawathe A, Liu S, Louie S, Sharma OP (2011) Fatigue and plasma cytokine concentrations at rest and during exercise in patients with sarcoidosis. Clin Respir J 5(3):156–164PubMedCrossRefGoogle Scholar
  11. 11.
    Drent M, Lower EE, De Vries J (2012) Sarcoidosis-associated fatigue. Eur Respir J 40(1):255–263PubMedCrossRefGoogle Scholar
  12. 12.
    Mostard RL, Voo S, van Kroonenburgh MJ, Verschakelen JA, Wijnen PA, Nelemans PJ, Erckens RJ, Drent M (2011) Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis. Respir Med 105(12):1917–1924PubMedCrossRefGoogle Scholar
  13. 13.
    Lopes AJ, de Menezes SL, Dias CM, de Oliveira JF, Mainenti MR, Guimaraes FS (2011) Comparison between cardiopulmonary exercise testing parameters and computed tomography findings in patients with thoracic sarcoidosis. Lung 189(5):425–431PubMedCrossRefGoogle Scholar
  14. 14.
    Gafa G, Sverzellati N, Bonati E et al (2012) Follow-up in pulmonary sarcoidosis: comparison between HRCT and pulmonary function tests. Radiol Med 117(6):968–978PubMedCrossRefGoogle Scholar
  15. 15.
    Erdal BS, Crouser ED, Yildiz V, King MA, Patterson AT, Knopp MV, Clymer BD (2012) Quantitative computerized two-point correlation analysis of lung CT scans correlates with pulmonary function in pulmonary sarcoidosis. Chest doi: 10.1378/chest.11-2027
  16. 16.
    Nunes H, Uzunhan Y, Gille T, Lamberto C, Valeyre D, Brillet PY (2012) Imaging of sarcoidosis of the airways and lung parenchyma with correlation with lung function. Eur Respir J 40(3):750–765PubMedCrossRefGoogle Scholar
  17. 17.
    Miller A, Brown LK, Sloane MF, Bhuptani A, Teirstein AS (1995) Cardiorespiratory responses to incremental exercise in sarcoidosis patients with normal spirometry. Chest 107(2):323–329PubMedCrossRefGoogle Scholar
  18. 18.
    Barros WG, Neder JA, Pereira CA, Nery LE (2004) Clinical, radiographic and functional predictors of pulmonary gas exchange impairment at moderate exercise in patients with sarcoidosis. Respiration 71(4):367–373PubMedCrossRefGoogle Scholar
  19. 19.
    Athos L, Mohler JG, Sharma OP (1986) Exercise testing in the physiologic assessment of sarcoidosis. Ann N Y Acad Sci 465:491–501PubMedCrossRefGoogle Scholar
  20. 20.
    Karetzky M, McDonough M (1996) Exercise and resting pulmonary function in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 13(1):43–49PubMedGoogle Scholar
  21. 21.
    Baughman RP, Lower EE (2007) Six-minute walk test in managing and monitoring sarcoidosis patients. Curr Opin Pulm Med 13(5):439–444PubMedGoogle Scholar
  22. 22.
    Marcellis RG, Lenssen AF, Elfferich MD, De Vries J, Kassim S, Foerster K, Drent M (2011) Exercise capacity, muscle strength and fatigue in sarcoidosis. Eur Respir J 38(3):628–634PubMedCrossRefGoogle Scholar
  23. 23.
    Medinger AE, Khouri S, Rohatgi PK (2001) Sarcoidosis: the value of exercise testing. Chest 120(1):93–101PubMedCrossRefGoogle Scholar
  24. 24.
    Risk C, Epler GR, Gaensler EA (1984) Exercise alveolar-arterial oxygen pressure difference in interstitial lung disease. Chest 85(1):69–74PubMedCrossRefGoogle Scholar
  25. 25.
    Bradvik I, Wollmer P, Blom-Bulow B, Albrechtsson U, Jonson B (1991) Lung mechanics and gas exchange during exercise in pulmonary sarcoidosis. Chest 99(3):572–578PubMedCrossRefGoogle Scholar
  26. 26.
    Lopes AJ, Menezes SL, Dias CM, Oliveira JF, Mainenti MR, Guimaraes FS (2012) Cardiopulmonary exercise testing variables as predictors of long-term outcome in thoracic sarcoidosis. Braz J Med Biol Res 45(3):256–263PubMedCrossRefGoogle Scholar
  27. 27.
    Bourbonnais JM, Samavati L (2008) Clinical predictors of pulmonary hypertension in sarcoidosis. Eur Respir J 32(2):296–302PubMedCrossRefGoogle Scholar
  28. 28.
    Corte TJ, Wells AU, Nicholson AG, Hansell DM, Wort SJ (2011) Pulmonary hypertension in sarcoidosis: a review. Respirology 16(1):69–77PubMedCrossRefGoogle Scholar
  29. 29.
    Hunninghake GW, Costabel U, Ando M et al (1999) ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16(2):149–173PubMedGoogle Scholar
  30. 30.
    Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC (1993) Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 16:5–40PubMedGoogle Scholar
  31. 31.
    Rothkrantz-Kos S, van Dieijen-Visser MP, Mulder PG, Drent M (2003) Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. Clin Chem 49(9):1510–1517PubMedCrossRefGoogle Scholar
  32. 32.
    American College of Chest Physicians, American Thoracic Society (2003) ATS/ACCP Statement on cardiopulmonary exercise testing. Joint Statement of the American Thoracic Society (ATS) and the American College of Chest Physicians (ACCP) was adopted by the ATS Board of Directors and by the ACCP Health Science Policy Committee, November 1, 2001. Am J Respir Crit Care Med 167(2):211–277CrossRefGoogle Scholar
  33. 33.
    Warrell DA, Cox TM, Firth JD, Benz EJ (2005) Oxford textbook of medicine, 4th edn. Oxford University Press, New YorkGoogle Scholar
  34. 34.
    Wasserman K, Hansen JE, Sue DY, Stringer WW, Whipp BJ (2005) Principles of exercise testing and interpretation, 4th edn. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
  35. 35.
    Black LF, Hyatt RE (1969) Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 99:696–702PubMedGoogle Scholar
  36. 36.
    Harik-Khan RI, Wise RA, Fozard JL (1998) Determinants of maximal inspiratory pressure. The baltimore longitudinal study of aging. Am J Respir Crit Care Med 158(5 Pt 1):1459–1464PubMedGoogle Scholar
  37. 37.
    Mathiowetz V, Kashman N, Volland G, Weber K, Dowe M, Rogers S (1985) Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil 66(2):69–74PubMedGoogle Scholar
  38. 38.
    Michielsen HJ, De Vries J, Van Heck GL, Van de Vijver FJR, Sijtsma K (2004) Examination of the dimensionality of fatigue: the construction of the fatigue assessment scale (FAS). Eur J Psychol Assess 20(1):39–48CrossRefGoogle Scholar
  39. 39.
    Baydur A (2012) Recent developments in the physiological assessment of sarcoidosis: clinical implications. Curr Opin Pulm Med 18(5):499–505PubMedCrossRefGoogle Scholar
  40. 40.
    Spruit MA, Thomeer MJ, Gosselink R, Troosters T, Kasran A, Debrock AJ, Demedts MG, Decramer M (2005) Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax 60(1):32–38PubMedCrossRefGoogle Scholar
  41. 41.
    Wirnsberger RM, Drent M, Hekelaar N, Breteler MH, Drent S, Wouters EF, Dekhuijzen PN (1997) Relationship between respiratory muscle function and quality of life in sarcoidosis. Eur Respir J 10(7):1450–1455PubMedCrossRefGoogle Scholar
  42. 42.
    Wallaert B, Talleu C, Wemeau-Stervinou L, Duhamel A, Robin S, Aguilaniu B (2011) Reduction of maximal oxygen uptake in sarcoidosis: relationship with disease severity. Respiration 82(6):501–508PubMedCrossRefGoogle Scholar
  43. 43.
    Sietsema KE, Kraft M, Ginzton L, Sharma OP (1992) Abnormal oxygen uptake responses to exercise in patients with mild pulmonary sarcoidosis. Chest 102(3):838–845PubMedCrossRefGoogle Scholar
  44. 44.
    De Vries J, Rothkrantz-Kos S, van Dieijen-Visser MP, Drent M (2004) The relationship between fatigue and clinical parameters in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 21(2):127–136PubMedGoogle Scholar
  45. 45.
    Ingram CG, Reid PC, Johnston RN (1982) Exercise testing in pulmonary sarcoidosis. Thorax 37(2):129–132PubMedCrossRefGoogle Scholar
  46. 46.
    Arena R, Sietsema KE (2011) Cardiopulmonary exercise testing in the clinical evaluation of patients with heart and lung disease. Circulation 123(6):668–680PubMedCrossRefGoogle Scholar
  47. 47.
    Kollert F, Geck B, Suchy R et al (2011) The impact of gas exchange measurement during exercise in pulmonary sarcoidosis. Respir Med 105(1):122–129PubMedCrossRefGoogle Scholar
  48. 48.
    Palmero V, Sulica R (2010) Sarcoidosis-associated pulmonary hypertension: assessment and management. Semin Respir Crit Care Med 31(4):494–500PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Rik G. J. Marcellis
    • 1
  • Antoine F. Lenssen
    • 1
  • Geeuwke J. de Vries
    • 2
  • Robert P. Baughman
    • 3
  • Chris P. van der Grinten
    • 4
  • Johny A. Verschakelen
    • 5
  • Jolanda De Vries
    • 6
  • Marjolein Drent
    • 7
    • 8
  1. 1.Department of Physical TherapyMaastricht University Medical Centre (MUMC)MaastrichtThe Netherlands
  2. 2.Department of Respiratory MedicineORBIS MCSittard-GeleenThe Netherlands
  3. 3.University of Cincinnati Medical CenterCincinnatiUSA
  4. 4.Department of Respiratory MedicineMaastricht University Medical Centre (MUMC)MaastrichtThe Netherlands
  5. 5.Department of RadiologyUniversity Hospital GasthuisbergLeuvenBelgium
  6. 6.Department of Medical Psychology, St. Elisabeth Hospital Tilburg and Center of Research on Psychology in Somatic Diseases (CoRPS)Tilburg UniversityTilburgThe Netherlands
  7. 7.Faculty of Health, Medicine and Life Sciences, Maastricht UniversityMaastrichtThe Netherlands
  8. 8.Department of interstitial lung diseasesGelderse Vallei HospitalEdeThe Netherlands

Personalised recommendations